Kleresca / Fb Dermatology

kleresca® is a research based company operating in the field of dermatology. through scientific progress and co-development with partner clinics, we aspire to transform the fundamentals of dermatology for the benefit of patients worldwide. at the core of our business is photobiomodulation (pbm) - a patented biophotonic technology using fluorescent light energy to stimulate the skin’s own biological processes and repair mechanisms. demonstrating high safety and efficacy, the pbm technology reduces inflammation, increases the build-up of collagen and normalises cellular activity. the technology is indicated for both therapeutic and aesthetic treatments. headquartered in dublin, ireland, kleresca® is built on the scientific heritage from leo pharma and klox technologies and is currently developing markets in australia, italy, france, spain, switzerland, germany, scandinavia, poland, canada and uk. kleresca® is also registered as fb dermatology. learn more at www.kleresca.com and www.fb-de